Verified review - view original I really like this product, I have definitely had success with it
Licensed clinicians can prescribe compounded pharmaceutical-grade topical GHK-Cu, but injectable GHK-Cu is restricted by the FDA
The Phase 2b MARIPOSA trial evaluated oral bedtime doses of AD109 in adults with mild to severe OSA and included patients with or without obesity and those with or without prior use of PAP therapy
The SURMOUNT-1 trial demonstrated significant weight loss, with patients losing approximately 15-21% of their body weight at the 15 mg dose over 72 weeks, depending on the statistical method used
Medical nutrition in the GLP-1 era: Protein strategies, micronutrient monitoring, and lean mass preservation
C-reactive protein and inflammatory markers CRP, the most commonly measured marker of systemic inflammation, begins declining within the first three months of semaglutide treatment